OACC
Oaktree Acquisition Corp III Life Sciences
OACC
OACC
39 hedge funds and large institutions have $153M invested in Oaktree Acquisition Corp III Life Sciences in 2025 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 3 increasing their positions, 7 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
30.36% more ownership
Funds ownership: 45.45% → 75.81% (+30%)
57% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 7
Holders
39
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$9.18M | |
| 2 | +$8.79M | |
| 3 | +$7.14M | |
| 4 |
LA
Linden Advisors
New York
|
+$6.12M |
| 5 |
Goldman Sachs
New York
|
+$5.42M |
Top Sellers
| 1 | -$9.7M | |
| 2 | -$5.4M | |
| 3 | -$4.5M | |
| 4 |
SCM
Shaolin Capital Management
Miami,
Florida
|
-$3.07M |
| 5 |
Verition Fund Management
Greenwich,
Connecticut
|
-$542K |